Sodium Hyaluronate
AI Summary
UnitedHealthcare has revised their Medical Benefit Drug Policy for Sodium Hyaluronate effective July 1, 2026. This policy update affects coverage and billing requirements for hyaluronic acid injections commonly used for joint pain and osteoarthritis treatment.
Action Required
By July 1, 2026: Billing team must review and implement the revised Sodium Hyaluronate policy requirements from UnitedHealthcare's Medical Policy Update Bulletin. Download the complete policy document from the UHC provider portal to identify specific coverage criteria, prior authorization requirements, and documentation standards. Update billing workflows and inform providers of any new requirements for hyaluronic acid injection claims.
Plan Types
Commercial
Specialties
ortho, rheumatology, pain-management, sports-medicine, pm-r